Skip to main content
Clinical Trials/NCT05885984
NCT05885984Not yet recruitingNot Applicable

Effects of Acceptance and Commitment Therapy on Fatigue Interference in Patients With Advanced Lung Cancer and Caregiver Burden: A Pilot Randomised Controlled Trial

Chinese University of Hong Kong1 site in 1 country80 target enrollmentStarted: July 1, 2023Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
80
Locations
1
Primary Endpoint
Recruimtment rate

Study Overview

Brief Summary

Lung cancer is a malignant tumour that has transformed from a single cancer disease into one of the most striking global health problems. Lung cancer has an insidious onset, and most patients are first diagnosed with the middle and advanced stages. Cancer-related fatigue is the most common and distressing symptom reported by lung cancer patients. For cancer patients, fatigue has a lasting impact on physical, psychological and social functions, and interferes with activities and participating in life events, thereby worsening the health-related quality of life. Family members have a key role in providing advanced lung cancer patients with informational, instrumental, and emotional support, which is crucial to patients' adaptation to the advanced illness and living a meaningful cancer life. Acceptance and Commitment Therapy (ACT) is the third-wave cognitive behavioural therapy to improve functioning and health-related quality of life by increasing psychological flexibility. The study aims to examine test the feasibility and acceptability, and preliminary effects of online ACT on fatigue interference in patients with advanced lung cancer and caregiver burden.

Detailed Description

A two-arm, assessor-blind randomised controlled trial will be conducted to investigate the effects of ACT on advanced lung cancer patients and caregivers compared to educational control. Participants in the same ward will be randomised at a 1:1 ratio to the intervention group or control group. Block randomization will be conducted by an independent research assistant using randomly varying block sizes of 4 and 6 to avoid selection bias. The study aims to examine the feasibility and acceptability, and preliminary effects of online ACT on fatigue interference in patients with advanced lung cancer and caregiver burden. The Specific objectives are:

  1. To investigate the feasibility and acceptability of the online 6-week ACT in patients with advanced lung cancer and caregivers in rural areas in China;
  2. To investigate the preliminary effects of the online 6-week ACT in patients with advanced lung cancer and caregivers in rural areas in China;
  3. To explore how patients and caregivers perceive the ACT experience during the intervention process.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
Single (Outcomes Assessor)

Masking Description

The outcomes assessor who is independent of the research will be trained before formally conducting data collecting.

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •aged 18 or over;
  • •diagnosed with stage III or stage IV lung cancer by pathological section or cytology;
  • •lived in rural areas;
  • •experienced unexplained fatigue syndrome: the score of 3 or more on the Fatigue Symptom Inventory (FSI);
  • •able to provide informed consent and effectively collect data;
  • •a consenting primary family caregiver; and
  • •working phone service

Exclusion Criteria

  • •diagnosed with cognitive dysfunction or other mental illnesses that may interfere with their completion of treatment;
  • •who are at critical condition; and
  • •who are receiving or have just completed other lung cancer-related intervention programs within the last six months

Arms & Interventions

ACT group

Experimental

Participants in the intervention group will receive ACT intervention, consisting of six online sessions via video conferencing platform (The first two sessions for patient only, the third and fourth sessions for caregiver only, and the last two sessions for patient-caregiver dyads) of 60-90 min each (once/week), in addition to health education.

Intervention: Acceptance and Commitment Therapy (ACT) plus health education (Behavioral)

Health eduction control group

Other

Participants randomised to the health education control group will receive six weekly health education by a video-conferencing platform. The topics mainly include treatments and daily care during admission, medication instructions and side effects, diet and exercise advice, and retest recommendations when discharged.

Intervention: Health education (Other)

Outcomes

Primary Outcomes

Recruimtment rate

Time Frame: Before baseline

The recruitment rate is defined as the percentage of participants who consented to participate in the study amongst the participants eligible for the study

Change from baseline in the score of fatigue interference assessed by The Fatigue Symptom Inventory at one week after the intervention

Time Frame: Baseline (T0) and post-intervention (T1, one week after the 6-week intervention)

A 13-item instrument that measures the intensity and interference of fatigue over the previous 7 days. The first four items are used to assess the intensity of fatigue, Item 5 - Item 11 are to assess the degree to which fatigue in the past week was judged to interfere with different aspects, such as general activity, bathe and dress ability, work activity, concentration ability, relation with others, enjoyment of life and mood, using a 11-point Likert scale ranging from 0 (no interference) to 10 (extreme interference). 0 indicates no fatigue and 127 indicates the worst fatigue intensity and interference.

Change from baseline in the score of caregiver burden assessed by The Zarit Caregiver Burden Inventory at one week after the intervention

Time Frame: Baseline (T0) and post-intervention (T1, one week after the 6-week intervention)

12 items score from 1(not always) to 5 (always) to assess caregiver burdens of caregivers of advanced lung cancer patients, including three domains: role strain, self-criticism, and negative emotion. The overall score can be obtained by adding all subscale scores. 12 indicates low caregiver burden and 60 indicates the highest caregiver burden.

Adherence rate

Time Frame: After the 6-week intervention

The adherence rate is defined as the frequency of the practice of mindfulness and session attendance

Eligibility rate

Time Frame: Before baseline

The eligiblity rate is defined as the percentage of participants fulfilling the inclusion criteria amongst the participants screened for the eligibility

Attrition rate

Time Frame: After the 6-week intervention

The attrition rate is defined as the percentage of participants who withdrew from the study before completion

Secondary Outcomes

  • Change from baseline in the score of mindful attention assessed by Mindful Attention Awareness Scale at one week after the intervention(Baseline (T0) and post-intervention (T1, one week after the 6-week intervention))
  • Change from baseline in the score of meanfing of life assessed by The Meaning of Life questionnaire (MLQ) at one week after the intervention(Baseline (T0) and post-intervention (T1, one week after the 6-week intervention))
  • Change from baseline in the score of health-related quality of life assessed by Functional Assessment of Cancer Therapy - Lung, Version 4 at one week after the intervention(Baseline (T0) and post-intervention (T1, one week after the 6-week intervention))
  • Change from baseline in the score of psychological flexibility assessed by Comprehensive assessment of Acceptance and Commitment Therapy processes at three months after the intervention(Baseline (T0) and post-intervention (T1, one week after the 6-week intervention))

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Huiyuan LI

Principal Investigator

Chinese University of Hong Kong

Study Sites (1)

Loading locations...

Similar Trials

Acceptance and Commitment Therapy on... | Clinical Trial